Subrata Kar | Clinical Trials | Best Researcher Award

Dr. Subrata Kar | Clinical Trials | Best Researcher Award

Subrata Kar at Virginia Commonwealth University | United States

Dr. Subrata Kar is a distinguished interventional cardiologist and academic leader currently serving as Associate Professor of Medicine at Virginia Commonwealth University and Interventional Cardiologist at the Veterans Affairs Medical Center in Richmond, Virginia. With specialization in structural heart disease, peripheral vascular intervention, and advanced heart failure and transplant cardiology, Dr. Kar has held leadership roles at multiple prestigious institutions including UCLA, Texas Tech University, and NYC Health + Hospitals. He has been instrumental in launching advanced cardiology programs, mentoring trainees, and leading clinical and academic departments. His work reflects a deep commitment to patient care, education, and cardiovascular innovation.

Publication Profile 

Orcid

Education 

Dr. Kar earned his Doctor of Osteopathic Medicine from the New York College of Osteopathic Medicine, where he also completed a Neuroanatomy Fellowship. He holds dual bachelor’s degrees in Bio-Mathematics and Biology from Rutgers University. His post-graduate training includes an internal medicine residency at the Cleveland Clinic, followed by a cardiovascular medicine fellowship at the University of Missouri-Columbia. He further specialized with interventional cardiology fellowships at Stony Brook University and UCLA, where he also trained in structural and congenital heart disease. Additionally, he completed an advanced heart failure and transplant cardiology fellowship at NYU Langone Medical Center.

Experience 

Dr. Kar has served in diverse clinical, academic, and leadership roles across major medical institutions in the U.S. Currently an Interventional Cardiologist and Advanced Heart Failure specialist at VCU/VA Medical Center, he previously held senior positions at Middletown Medical, NYC Health + Hospitals, Texas Tech University, and UCLA. His roles have included Division Chief, Director of Interventional Cardiology, and Chair of Fellowship Selection Committees. He has also worked as a hospitalist at the Cleveland Clinic and a clinical instructor at UCLA. His experience reflects comprehensive expertise in interventional cardiology, structural heart interventions, and academic program development.

Awards and Honors 

Dr. Kar has received recognition for both clinical excellence and academic leadership. At UCLA and Texas Tech, he was instrumental in program development and fellowship training, earning him leadership roles such as Chair of the Academic Cardiology Section of the American College of Cardiology (Texas Chapter). He has been invited to present at national cardiology conferences and served on key committees evaluating trainee competency. His pioneering clinical program launches, particularly in interventional cardiology at Coney Island Hospital, highlight his innovation and impact. His mentorship and contributions to cardiology education have also been widely commended by academic and hospital leadership.

Research Focus 

Dr. Kar’s research centers on structural heart disease, adult congenital heart defects, interventional cardiology techniques, and advanced heart failure therapies. He has explored minimally invasive cardiovascular interventions, radiation reduction in catheterization procedures (KAR RAD study), and cardiac CT applications. He has presented nationally on outcomes in percutaneous valve procedures and congenital heart disease management. His work also includes developing safety protocols and training programs in cardiac catheterization labs. Through his research, he integrates clinical innovation with academic insight, advancing cardiovascular treatment and education, especially in underserved populations. His mentoring of trainees in research further amplifies his academic reach.

Publication Top Notes

Application and Outcomes of Minimal-Dose Versus Standard-Dose Radiation in Peripheral Endovascular Intervention (KAR Endovascular Study)

Meixian Zhang | Clinical Trials | Best Researcher Award

Dr. Meixian Zhang | Clinical Trials | Best Researcher Award

Director at Taizhou Hospital of Zhejiang Province | China

Dr. Meixian Zhang is an Associate Researcher and Master’s Supervisor at Wenzhou Medical University. With a Ph.D. in Public Health, she specializes in clinical epidemiology, evidence-based medicine, and obesity research. Her career is marked by over 35 SCI journal publications and leadership in multiple national and provincial research projects. She is deeply committed to tackling childhood obesity through genetic and dietary studies. With a passion for translational health research and mentoring, Dr. Zhang has earned recognition through innovation, impactful findings, and dedicated academic service. She continues to push boundaries in the fight against obesity-related health risks.

Publication Profile 

Orcid

Education

Dr. Zhang Meixian earned her Ph.D. in Public Health, specializing in childhood obesity and molecular epidemiology. Her academic journey began with a strong foundation in clinical medicine and public health, followed by doctoral research focusing on genetic predisposition to pediatric adiposity. She has been trained extensively in clinical epidemiology, biostatistics, and molecular genetics. Her postgraduate training enabled her to explore multifaceted aspects of obesity-related metabolic disorders and the implementation of evidence-based interventions. The academic rigor and scientific integrity developed during her education continue to guide her ongoing contributions to translational research and public health education.

Experience

With over a decade of research and academic experience, Dr. Zhang currently serves as an Associate Researcher at Wenzhou Medical University. She has supervised graduate students and led numerous scientific projects as principal investigator. Her work bridges molecular epidemiology, public health policy, and clinical research. She’s received major grants from the National Natural Science Youth Fund and Zhejiang provincial programs. She has also contributed to high-impact studies on obesity, SNPs, and weight management. Through editorial appointments and cross-institution collaborations, she continues to expand the reach of her research across China and the global scientific community.

Awards 

Dr. Zhang has received significant recognition for her contributions to medical research. She has been awarded grants from the National Natural Science Youth Fund and the Basic Public Welfare Research Program of Zhejiang Province as a Principal Investigator. Additionally, she has secured two provincial-level medical and science grants and one from the Taizhou Science and Technology Council. Her innovative research has led to two authorized national invention patents and one software copyright. These accolades underscore her scientific excellence and translational impact in obesity and metabolic health, positioning her as a leading figure in evidence-based public health research.

Research Focus 

Dr. Zhang’s research centers on childhood obesity, metabolic syndrome, and genetic susceptibility markers. She investigates the role of leptin, adiponectin, FTO gene variants, and other biomarkers in the development of obesity. Her work bridges molecular epidemiology with clinical nutrition, validating interventions such as intermittent fasting, calorie restriction, and meal replacements. Additionally, she explores single-nucleotide polymorphisms (SNPs) and their regulatory functions in metabolic pathways. Dr. Zhang’s interdisciplinary approach integrates public health, genomics, and preventive medicine, aiming to deliver targeted health strategies for pediatric populations in China and globally.

Top Publications

Title: Willingness of Older Adults with Chronic Diseases to Receive a Booster Dose of Inactivated Coronavirus Disease 2019 Vaccine: A Cross-Sectional Study in Taizhou
Year: 2025

Conclusion

Dr. Zhang Meixian’s academic rigor, originality, and focused contributions in combating obesity through evidence-based and genetics-informed approaches position her as an outstanding candidate for the Best Researcher Award. Her ability to translate complex research into meaningful public health solutions, combined with her strong record of funding, publications, and innovation, make her a worthy and impactful recipient of this recognition. With minor strategic advancements, her global influence is poised to grow even further.

Mert Zeytinoğlu | Clinical Trials | Best Researcher Award

Mert Zeytinoğlu | Clinical Trials | Best Researcher Award

Assoc. Prof. Dr. Mert Zeytinoğlu, Ege University Faculty of Dentistry Department of Oral and Maxillofacial Surgery, Turkey

Assoc. Prof. Dr. Mert Zeytinoğlu is a distinguished academic at Ege University, Faculty of Dentistry, specializing in Oral and Maxillofacial Surgery. With a Ph.D. from Ege University (2004), his research spans oral surgery, clinical sciences, and dental implantology. He has authored over 40 publications, holds an H-index of 3, and has led numerous projects on piezosurgery, wound healing, and dental stem cells. Known for his contributions to surgical techniques and cardiovascular safety in dental anesthesia, Dr. Zeytinoğlu actively mentors postgraduate theses and advances innovative practices in dental science.

Publication Profile

Google Scholar

Education

Assoc. Prof. Dr. Mert Zeytinoğlu began his academic journey at Ege University, where he earned his Bachelor’s degree in Dentistry from the Faculty of Dentistry between 1993 and 1998. His dedication to clinical sciences led him to pursue a Ph.D. in the same institution, specializing in the Department of Clinical Sciences, which he successfully completed between 1999 and 2004. 🇹🇷 Throughout his education, he demonstrated a strong commitment to advancing dental knowledge and practice in Turkey. Dr. Zeytinoğlu’s academic foundation reflects his deep passion for oral health and clinical excellence.

Experience

Assoc. Prof. Dr. Mert Zeytinoğlu has built a distinguished academic career at Ege University’s Faculty of Dentistry. Since 2015, he has been serving as an Associate Professor in the Department of Clinical Sciences, contributing significantly to academic development and clinical training. 🏫 Earlier, from 1999 to 2004, he worked as a Specialist Doctor in the Division of Clinical Sciences, specifically in the Department of Oral and Maxillofacial Surgery, where he gained extensive hands-on experience in complex dental surgeries. 🦷🔬 His academic and clinical roles reflect a deep commitment to excellence in dental education and patient care.

Awards

Assoc. Prof. Dr. Mert Zeytinoğlu received a prestigious award in 2015 for his outstanding research titled “Süt dişi- mesiodens ve daimi molar dişlerin kök hücrelerinin immünohistokimyasal ve histokimyasal yöntemlerle belirlenmesi” (Determination of Stem Cells in Primary, Mesiodens, and Permanent Molar Teeth Using Immunohistochemical and Histochemical Methods). 🧬🦷 His project earned Second Place in the Project Competition of Occupational Organizations during the İzmir Chamber of Dentists Scientific Congress and Exhibition. 🎖️ This recognition highlights his innovative approach to dental research and his contributions to scientific advancement in stem cell applications within oral health.

Research Focus

Assoc. Prof. Dr. Mert Zeytinoğlu primarily focuses on Oral and Maxillofacial Surgery 🦷 and Dental Radiology, with special expertise in the diagnosis and surgical management of jaw pathologies, including cysts, tumors, and bone defects. His research includes the use of fractal analysis 📈, peri-implant bone assessment, and management of impacted third molars, as well as multidisciplinary approaches to benign jaw tumors and dental anomalies. He also investigates the cardiovascular effects of dental anesthetics ❤️, showing interest in dental care for medically compromised patients. His work bridges clinical surgery with diagnostic innovation and patient-centered dental care.

Publication Top Notes

Oral mucosal ulceration: a manifestation of previously undiagnosed pulmonary tuberculosis

Fractal analysis for the assessment of trabecular peri-implant alveolar bone using panoramic radiographs

Effect of tube drainage compared with conventional suturing on postoperative discomfort after extraction of impacted mandibular third molars

Treatment of nonsyndromic dentigerous cysts in primary dentition

Multidisciplinary Management of Benign Jaw Tumors in

Comparison of 2 different flap techniques in the surgical removal of bilateral impacted mandibular third molars

Holter ECG assessment of the effects of three different local anesthetic solutions on cardiovascular system in the sedated dental patients with coronary artery disease/Üç …

Myofibroma of the gingiva: report of a case